Delivery Order SPE2DB24D2205-SPE2DB25FDSGS

Award Date 10/7/24
Potential Completion Date 10/8/24
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of CARVEDILOL ER 10 MG CAPSULE 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $21,766.08. The contract is a Delivery Order and has a Firm Fixed Price pricing type. The period of performance runs through July 18, 2024. This contract is not set aside for any particular business type. Amerisourcebergen has been...
This federal contract award is for the delivery of CARVEDILOL ER 10 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $7,841.50, is a Firm Fixed Price Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 27, 2024. The contract has an ultimate completion date of September 30, 2024 and does not utilize any set-aside designations. Amerisourcebergen, through its corporate office division, has been awarded numerous federal...
This federal contract award is for the delivery of CARVEDILOL ER 40 MG CAPSULE 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 10, 2025, with a completion date of January 13, 2025. The contract has a firm fixed price of $5,947.94 and is a delivery order, not associated with a larger contracting vehicle. The contract does not have a set-aside...
The federal contract award is for the delivery of CARVEDILOL ER 20 MG CAPSULE 30S to the Defense Logistics Agency (DLA), a defense agency. The $1,504.93 fixed-price delivery order was awarded on May 18, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of May 19, 2025. The contract is not set aside and is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a...
This federal contract award is for the delivery of CARVEDILOL ER 10 MG CAPSULE 30S to the Defense Logistics Agency (DLA), a major agency within the Department of Defense. The contract, valued at $4,028.13, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of December 11, 2023, and is structured as a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,512.38 Firm Fixed Price Delivery Order contract is for the supply of 4566736632 CARVEDILOL ER 10 MG CAPSULE 30S, a cardiovascular medication. The contract has a ceiling value of $4,512.38 and a completion date of December 17, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of CARVEDILOL ER 80 MG CAPSULE 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract has a ceiling value of $83,725.44 and is a firm fixed-price delivery order with a period of performance through May 7, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $1,065.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CARVEDILOL ER 20 MG CAPSULE 30S, a prescription medication. This is a delivery order contract with a firm-fixed price. The contract has an ultimate completion date of August 15, 2024. Amerisourcebergen Drug Corp has been awarded this contract as well as several other Indefinite Delivery Contracts...
This federal contract award is for the delivery of CARVEDILOL ER 20 MG CAPSULE 30S to the Defense Logistics Agency (DLA). The award, valued at $1,522.34, was made to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a completion date of January 17, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC)...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of CARVEDILOL ER 10 MG CAPSULE 30S to support the Medical Supply Chain of the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $10,829.11, has a completion date of September 24, 2024. The contract does not have a set-aside designation. As a key supplier to the federal government, AmerisourceBergen holds several Indefinite Delivery Contracts...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDSGS
    Delivery Order

This federal contract award is for the delivery of CARVEDILOL ER 10 MG CAPSULE 30S to the Defense Logistics Agency (DLA), a major defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 7, 2024 with a ceiling value of $28,053.50. This is a delivery order contract with a firm fixed-price pricing type, and the ultimate completion date is October 8, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors. This contract appears to be part of Amerisourcebergen's broader supply of pharmaceutical products and medical supplies to various federal agencies, including the DLA, which is a significant customer for the company.

Generated 1/6/25, 12:27 PM